StartAngels Network
VC Fund
Zürich, Switzerland
StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries StartAngels Network invests in
Stages StartAngels Network invests in
Countries StartAngels Network invests in
Round sizes
Round size
- Seed
- $933k–$3.4M
- Series A
- $2M–$3.5M
- Series B
- $1.7M–$5.7M
Investment Focus
Industry
- Health Care 9 (29%)
- Medical 8 (26%)
- Medical Device 8 (26%)
- Manufacturing 4 (13%)
- Biotechnology 3 (10%)
Stage
- Seed 13 (42%)
- Series A 6 (19%)
- Series B 5 (16%)
- Series C 2 (6%)
- Angel 1 (3%)
Country
- Switzerland 23 (74%)
- Brazil 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs. | $1.9M / Seed / Jul 03, 2026 | ||
| Rflect helps universities protect their business model in the age of AI by training the human skills machines cannot replace—reflection, resilience, collaboration—directly inside the curriculum for credit. As AI commoditizes knowledge and devalues degrees, Rflect secures degree value through measurable human development and audit-ready data foraccreditation, employability, and retention. Embedded as credit-bearing infrastructure, Rflect achieves 100% student usage, zero institutional churn, and long-term lock-in cycles. | $1.2M / Seed / Jun 18, 2026 | ||
| Scanvio offers AI-augmented ultrasound software for faster endometriosis diagnosis, providing expert sonography skills to gynecologists, improving health and surgical education. | $3.4M / Seed / Jul 15, 2025 | ||
| Calingo is a digital insurance platform that offers personalised and optimised risk protection at the point of sale. | $3.7M / Seed / Aug 07, 2024 | ||
| Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland. | $5.1M / Series B / Sep 05, 2023 | ||
| Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland. | $4M / Series B / Jan 10, 2023 | ||
| Oxfia is an energy optimization platform. It can optimize and monitor existing building technology without human interaction and lower energy costs in the building process. They specialize in reducing carbon dioxide emissions and energy costs associated with the operation of building systems, enabling people to minimize their building's energycosts and reduce controllable energy consumption. | Seed / Jul 11, 2022 | ||
| Delirium is one of the largest issues in healthcare and is massively unaddressed. It represents a significantly higher cost than diabetes. Post-Operative Delirium (POD) is the most common post-surgical complication affecting 20% of patients over 60 with long-term consequences for patients and enormous costs to hospitals and insurers. OurCE-certified, A.I-driven clinical decision support software helps doctors identify high-risk patients prior to surgery. Highlighting high-risk patients allows for effective, cost-reducing measures to be implemented shown to decrease the incidence by 53%. We are currently live in 3 hospitals with 22 hospitals throughout Europe in our pipeline. Our advisory board includes 6 KOL’s from aroudn the world including in the U.S. from Johns Hopkins, Harvard and Cornell. | $2.2M / Seed / Jun 16, 2022 | ||
| REBELS 0.0% is on a social mission to FREE THE SPIRIT OF SPIRITS by developing truly alcohol-free 0.0% spirits and celebrating everyone’s freedom of choice. | $1.1M / Seed / Feb 28, 2022 | ||
| This EPFL spin-off is developing faster, portable energy units that offer ten times the power at half the weight of current technology. Founder Mahmoud Hadad’s fuel cell innovation, which uses standard butane or propane that’s safe and available worldwide, offers high autonomy. INERGIO’s fuel cell geometry allows unlimited scaling, making thetechnology suitable for applications ranging from charging consumer electronics to auxiliary power for drones to automobile fuel cells. The team has a working prototype and is looking to have its minimal viable product by summer 2020 to start the pilot project with potential partners and customers. | $1.4M / Pre-Seed / Jan 18, 2022 | ||
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does StartAngels Network invest in?
StartAngels Network invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Series A stage. Most of the 31 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does StartAngels Network invest in?
StartAngels Network typically joins rounds of $933k–$3.4M at Seed, $2M–$3.5M at Series A and $1.7M–$5.7M at Series B. These are whole funding-round sizes, not StartAngels Network's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds StartAngels Network took part in.
When did StartAngels Network last invest?
The most recent investment recorded for StartAngels Network closed in Jul 2026. Shizune tracks 31 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
